Kura Oncology, Inc. (NASDAQ:KURA) filed a Form 8-K with the Securities and Exchange Commission on January 29, 2026, disclosing a material event.
Kura Oncology, Inc.'s stock currently trades at $8.22 with a market capitalization of $911.1M. The Healthcare company's stock moved following the disclosure.